- CVD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $45.5 million.
- CVD traded 95,736 shares today in the pre-market hours as of 8:48 AM, representing 21.2% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CVD with the Ticky from Trade-Ideas. See the FREE profile for CVD NOW at Trade-Ideas More details on CVD: Covance Inc., a drug development services company, provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries worldwide. It operates in two segments, Early Development and Late-Stage Development. CVD has a PE ratio of 30.1. Currently there are 10 analysts that rate Covance a buy, 1 analyst rates it a sell, and 5 rate it a hold. The average volume for Covance has been 414,600 shares per day over the past 30 days. Covance has a market cap of $4.7 billion and is part of the health care sector and health services industry. The stock has a beta of 0.79 and a short float of 3.3% with 3.69 days to cover. Shares are down 9.9% year-to-date as of the close of trading on Thursday.